These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19904767)

  • 1. Activating NK-cell receptors co-stimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis.
    Fasth AE; Björkström NK; Anthoni M; Malmberg KJ; Malmström V
    Eur J Immunol; 2010 Feb; 40(2):378-87. PubMed ID: 19904767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis.
    Groh V; Bruhl A; El-Gabalawy H; Nelson JL; Spies T
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9452-7. PubMed ID: 12878725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.
    Warrington KJ; Takemura S; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2001 Jan; 44(1):13-20. PubMed ID: 11212151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
    Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
    Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
    Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.
    Park W; Weyand CM; Schmidt D; Goronzy JJ
    Eur J Immunol; 1997 May; 27(5):1082-90. PubMed ID: 9174596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis.
    Bryl E; Vallejo AN; Matteson EL; Witkowski JM; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2005 Oct; 52(10):2996-3003. PubMed ID: 16200579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis.
    Salazar-Fontana LI; Sanz E; Mérida I; Zea A; Sanchez-Atrio A; Villa L; Martínez-A C; de la Hera A; Alvarez-Mon M
    Clin Immunol; 2001 May; 99(2):253-65. PubMed ID: 11318597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis.
    Okamoto T; Saito S; Yamanaka H; Tomatsu T; Kamatani N; Ogiuchi H; Uchiyama T; Yagi J
    J Rheumatol; 2003 Jun; 30(6):1157-63. PubMed ID: 12784384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.
    Echeverría A; Moro-García MA; Asensi V; Cartón JA; López-Larrea C; Alonso-Arias R
    J Leukoc Biol; 2015 Sep; 98(3):373-84. PubMed ID: 26034206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
    Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytokine signaling 1 in CD4+ T cells from patients with rheumatoid arthritis.
    Yamana J; Yamamura M; Okamoto A; Aita T; Iwahashi M; Sunahori K; Makino H
    Arthritis Res Ther; 2004; 6(6):R567-77. PubMed ID: 15535835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
    Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis.
    Namekawa T; Snyder MR; Yen JH; Goehring BE; Leibson PJ; Weyand CM; Goronzy JJ
    J Immunol; 2000 Jul; 165(2):1138-45. PubMed ID: 10878393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-15 selectively expands CD57+ CD28- CD4+ T cells, which are increased in active rheumatoid arthritis.
    Yamada H; Kaibara N; Okano S; Maeda T; Shuto T; Nakashima Y; Okazaki K; Iwamoto Y
    Clin Immunol; 2007 Sep; 124(3):328-35. PubMed ID: 17644042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OX40 signaling is involved in the autoactivation of CD4
    Jiang J; Liu C; Liu M; Shen Y; Hu X; Wang Q; Wu J; Wu M; Fang Q; Zhang X
    Arthritis Res Ther; 2017 Mar; 19(1):67. PubMed ID: 28320444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis.
    Téo FH; de Oliveira RT; Mamoni RL; Ferreira MC; Nadruz W; Coelho OR; Fernandes Jde L; Blotta MH
    Cell Immunol; 2013 Jan; 281(1):11-9. PubMed ID: 23416719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.